PT1546152E - Derivados de epotilona - Google Patents

Derivados de epotilona Download PDF

Info

Publication number
PT1546152E
PT1546152E PT03747872T PT03747872T PT1546152E PT 1546152 E PT1546152 E PT 1546152E PT 03747872 T PT03747872 T PT 03747872T PT 03747872 T PT03747872 T PT 03747872T PT 1546152 E PT1546152 E PT 1546152E
Authority
PT
Portugal
Prior art keywords
epothilone
analogs
epothilone derivatives
epoxide
potent
Prior art date
Application number
PT03747872T
Other languages
English (en)
Inventor
Kyriacos Costa Nicolaou
Kenji Namoto
Andreas Ritzen
Original Assignee
Scripps Research Inst
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst, Novartis Ag filed Critical Scripps Research Inst
Publication of PT1546152E publication Critical patent/PT1546152E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Polymers (AREA)
  • Dental Preparations (AREA)
PT03747872T 2002-08-02 2003-08-01 Derivados de epotilona PT1546152E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40053502P 2002-08-02 2002-08-02
US48093303P 2003-06-24 2003-06-24

Publications (1)

Publication Number Publication Date
PT1546152E true PT1546152E (pt) 2008-03-12

Family

ID=31720540

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03747872T PT1546152E (pt) 2002-08-02 2003-08-01 Derivados de epotilona

Country Status (12)

Country Link
US (2) US7169930B2 (pt)
EP (1) EP1546152B1 (pt)
JP (1) JP4276171B2 (pt)
CN (1) CN100439374C (pt)
AT (1) ATE381569T1 (pt)
AU (1) AU2003266961A1 (pt)
BR (1) BR0313198A (pt)
CA (1) CA2494259A1 (pt)
DE (1) DE60318224T2 (pt)
ES (1) ES2297189T3 (pt)
PT (1) PT1546152E (pt)
WO (1) WO2004014919A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756699B2 (en) * 1996-12-03 2003-01-23 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6660758B1 (en) * 1996-12-13 2003-12-09 The Scripps Research Institute Epothilone analogs
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
JP4791183B2 (ja) 2002-08-23 2011-10-12 スローン−ケッタリング インスティトュート フォア キャンサー リサーチ エポチロン、その中間体、類似体の合成およびその使用
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
WO2005020989A1 (en) * 2003-09-02 2005-03-10 Novartis Ag Cancer treatment with epothilones
GB0405898D0 (en) 2004-03-16 2004-04-21 Novartis Ag Organic compounds
US20060121511A1 (en) 2004-11-30 2006-06-08 Hyerim Lee Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
CN101535492A (zh) 2005-02-11 2009-09-16 南加州大学 表达含有二硫键的蛋白质的方法
CN101360494A (zh) * 2005-11-22 2009-02-04 斯克里普斯研究学院 高效埃博霉素的化学合成
WO2007130501A2 (en) * 2006-05-01 2007-11-15 University Of Southern California Combination therapy for treatment of cancer
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity
AU2011255647A1 (en) 2010-05-18 2012-11-15 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
US9717803B2 (en) 2011-12-23 2017-08-01 Innate Pharma Enzymatic conjugation of polypeptides
EP2872894B1 (en) 2012-07-13 2019-04-17 Innate Pharma Screening of conjugated antibodies
US10036010B2 (en) 2012-11-09 2018-07-31 Innate Pharma Recognition tags for TGase-mediated conjugation
WO2014140300A1 (en) 2013-03-15 2014-09-18 Innate Pharma Solid phase tgase-mediated conjugation of antibodies
US10071169B2 (en) 2013-06-20 2018-09-11 Innate Pharma Enzymatic conjugation of polypeptides
AU2014283185B2 (en) 2013-06-21 2019-05-02 Innate Pharma Enzymatic conjugation of polypeptides
WO2019092148A1 (en) 2017-11-10 2019-05-16 Innate Pharma Antibodies with functionalized glutamine residues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380394B1 (en) * 1996-12-13 2002-04-30 The Scripps Research Institute Epothilone analogs
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
US6380395B1 (en) * 1998-04-21 2002-04-30 Bristol-Myers Squibb Company 12, 13-cyclopropane epothilone derivatives
PT1420780E (pt) * 2001-08-23 2008-12-29 Novartis Ag Análogos ciclopropilados e ciclobutilados da epotilona
WO2003026744A1 (en) * 2001-09-25 2003-04-03 Alcon, Inc. The use of epothilones and analogs in conjunction with ophthalmic surgery

Also Published As

Publication number Publication date
ES2297189T3 (es) 2008-05-01
CN100439374C (zh) 2008-12-03
CA2494259A1 (en) 2004-02-19
DE60318224D1 (de) 2008-01-31
US20040072870A1 (en) 2004-04-15
US7169930B2 (en) 2007-01-30
WO2004014919A1 (en) 2004-02-19
EP1546152A1 (en) 2005-06-29
AU2003266961A1 (en) 2004-02-25
BR0313198A (pt) 2005-07-12
CN1675220A (zh) 2005-09-28
ATE381569T1 (de) 2008-01-15
EP1546152B1 (en) 2007-12-19
JP2006503814A (ja) 2006-02-02
US20060293527A1 (en) 2006-12-28
DE60318224T2 (de) 2009-01-29
JP4276171B2 (ja) 2009-06-10

Similar Documents

Publication Publication Date Title
PT1546152E (pt) Derivados de epotilona
NZ607880A (en) Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production
UA88626C2 (en) Neck brace
UY27878A1 (es) Derivados de indolinfenilsulfonamida
ECSP055626A (es) Nuevos conjugados de efectores, procedimientos para su preparación y su uso farmacéutico
PL374588A1 (en) Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides
IL162461A0 (en) Polymorphs of clopidogrel hydrogensulfate
UY28294A1 (es) Dihidroquinazolinas sustituidas
EP1621226A4 (en) REMOVABLE SOFT STENT WITH EXCELLENT ABILITY TO FOLLOW A BLOOD VESSEL
HK1089671A1 (en) Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
ECSP056057A (es) Compuestos de benzo[1,2,5]tiadiazole
TW200637806A (en) 2-alkylcycloalk(en)ylcarboxamides
UY29189A1 (es) Nonadepsipeptidos acilados ii
EP1629861A4 (en) SOFT STENT WITH EXCELLENT BLOOD VESSEL TRACKING
HN2006007774A (es) Imidazoles sustituidos con heterociclilamida
DOP2006000024A (es) Tiazolidinonas, su preparación y su uso como medicamento
UY28542A1 (es) Amidas macrocíclicas antibacterianas
EP1387108A3 (de) Radiallager
EA200500326A1 (ru) Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента
UY27733A1 (es) Derivados de ciclopenteno.
TW200732327A (en) Novel compound
AU2003227593A1 (en) New analogs of nitrobenzylthioinosine
AU2003285404A1 (en) Method for cosmetic body treatment to enhance the silhouette and to develop the female bust, and double-acting cosmetic composition therefor
WO2005000843A3 (fr) Benzothiazole-4,7-diones et benzoxazole-4,7-diones substituees en position 5 ou 6 et leurs procedes de preparation
ATE275551T1 (de) Halogenpyrimidine